Human Siglec-7/CD328 Antibody, R&D Systems™

Siglec-7/CD328

Monoclonal

LYOPH

Flow Cytometry 0.25 ug/10^6 cells, CyTOF-reported

Q9Y286

SIGLEC7

Mouse myeloma cell line NS0-derived recombinant human Siglec-7 Gln19-Gly357 (predicted) Accession # Q9Y286

25 μg

Primary

Detects human Siglec-7 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human Siglec-6, -8, -9 or recombinant Siglec-E is observed.

Human

Purified

Flow Cytometry, CyTOF

194211

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

Adhesion inhibitory receptor molecule 1, adhesion inhibitory receptor molecule 1, siglec-7, AIRM1, AIRM-1, AIRM1QA79 membrane protein, CD328, CD328 antigen, CDw328, D-siglec, p75, p75/AIRM1, QA79, sialic acid binding Ig-like lectin 7, sialic acid binding immunoglobulin-like lectin 7, sialic acid-binding Ig-like lectin 7, Siglec7, Siglec-7

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

27036

Sterile PBS to a final concentration of 0.5 mg/mL.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG1